ICU

NASDAQ 已收盘

SeaStar Medical Holding

0.94 USD
▼-0.12-10.95%
盘后 0.89 -4.61%
2026-11-20
市值
$4.97M
市盈率
—
EPS
-3.66
股息率
—
52 周区间
0.76 – 5.38
成交量
135.82K
Beta
-1.04
目标价
10.00
52W 低 0.7652W 高 5.38
价格走势

公司简介

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SC...